UNIV OF ARKANSAS FOR MED SCIS
COBRE Phase III
COBRE Phase III is a funding opportunity from UNIV OF ARKANSAS FOR MED SCIS, up to 1147500, closing May 31, 2030.
May 31, 2030
(1400d left)Overview
Overall – Project Summary/Abstract The overall goal of the Center for Studies of Host Response to Cancer Therapy at the University of Arkansas for Medical Sciences (UAMS) is to become a self-sustaining multidisciplinary center for research excellence that contributes to our understanding of mechanisms for side…